HighQ partners with SAFE-BioPharma

Wednesday, December 7, 2011 12:23 PM

London-based HighQ has formed a vendor partnership with the SAFE-BioPharma Association. Companies within the global pharmaceutical and biotechnology industry use the SAFE-BioPharma standard in FDA Title 21 CFR part 11 compliant processes for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents and more.

HighQ provides the life sciences industry with a unified space for secure document exchange and social collaboration across a global network of employees, researchers and partners – both internal and external to the company. HighQ Collaborate, a secure cloud-based platform, allows users to disseminate information to discovery teams, CROs, investigators and business development partners worldwide. Users will have the opportunity to securely exchange documents using their SAFE-BioPharma digital identities on the HighQ Collaborate platform, ensuring their credentials are available anytime and anywhere.

"By making use of collaborative tools such as wiki pages and blog posts alongside traditional office software (Word, Excel, PowerPoint, PDF etc.), sponsors, CROs and investigators can work more efficiently, eliminating the time consuming need to print out physical documents that require signatures during clinical trials. By partnering with the SAFE-BioPharma Association, HighQ will enable the life sciences industry to have an efficient, enforceable and regulatory-compliant document approval process, whilst facilitating secure document exchange and social collaboration throughout the organization," said Jacob Mathew, consultant – KM Practice, HighQ.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs